These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7719529)

  • 1. FDA panel gives cautious signal to summit.
    Moretti M
    J Refract Corneal Surg; 1994; 10(6):613-4. PubMed ID: 7719529
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA panel recommends conditional approval of excimer laser phototherapeutic keratectomy (PTK).
    Waring GO
    J Refract Corneal Surg; 1994; 10(2):77-8. PubMed ID: 7517291
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimists predict photorefractive keratectomy approval in 1994.
    Moretti M
    J Refract Corneal Surg; 1994; 10(1):7-8. PubMed ID: 7517785
    [No Abstract]   [Full Text] [Related]  

  • 4. Intense competition shapes PRK delivery market.
    Moretti M
    J Refract Surg; 1995; 11(3):160. PubMed ID: 7553083
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA takes on maker of "homemade" excimer lasers.
    Kearns LA
    J Refract Surg; 1995; 11(5):331-2. PubMed ID: 8528908
    [No Abstract]   [Full Text] [Related]  

  • 6. International photorefractive keratectomy market thrives while FDA stalls.
    Moretti M
    Refract Corneal Surg; 1993; 9(5):326-7. PubMed ID: 8241036
    [No Abstract]   [Full Text] [Related]  

  • 7. Checklist of information usually submitted in an investigational device exemption (IDE) application for refractive surgery lasers. Ophthalmic Devices Advisory Panel, Food and Drug Administration.
    J Refract Surg; 1997; 13(6):579-88. PubMed ID: 9352487
    [No Abstract]   [Full Text] [Related]  

  • 8. Custom excimer users threaten PRK success.
    Moretti M
    J Refract Surg; 1995; 11(5):333-4. PubMed ID: 8528909
    [No Abstract]   [Full Text] [Related]  

  • 9. Home-made excimer lasers are operating today in the US--the rest of the country watches and waits.
    Kremer FB
    J Refract Surg; 1995; 11(5):328. PubMed ID: 8528907
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluating new refractive surgical procedures: free market madness versus regulatory rigor mortis.
    Waring GO
    J Refract Surg; 1995; 11(5):335-9. PubMed ID: 8528910
    [No Abstract]   [Full Text] [Related]  

  • 11. Clarification: 510k is premarket notification; it provides no patent or FDA approval.
    Burkhart CG
    J Drugs Dermatol; 2008 Feb; 7(2):105. PubMed ID: 18335644
    [No Abstract]   [Full Text] [Related]  

  • 12. Cosmetic medical devices and their FDA regulation.
    Newburger AE
    Arch Dermatol; 2006 Feb; 142(2):225-8. PubMed ID: 16490851
    [No Abstract]   [Full Text] [Related]  

  • 13. Judicial review of FDA preemption determinations.
    Frost A
    Food Drug Law J; 1999; 54(3):367-88. PubMed ID: 11797704
    [No Abstract]   [Full Text] [Related]  

  • 14. The FDA and the spine surgeon.
    Ducker TB
    J Spinal Disord; 1999 Aug; 12(4):277-9. PubMed ID: 10451041
    [No Abstract]   [Full Text] [Related]  

  • 15. Excimer laser photorefractive keratectomy. The Food and Drug Administration panel speaks.
    McDonnell PJ
    Arch Ophthalmol; 1995 Jul; 113(7):858-9. PubMed ID: 7605273
    [No Abstract]   [Full Text] [Related]  

  • 16. Two intravascular brachytherapy systems approved by FDA.
    SoRelle R
    Circulation; 2000 Nov; 102(21):E9041-3. PubMed ID: 11185473
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA set to tighten guidelines on industry dissemination of information on unapproved uses of medical products.
    Lang L
    Gastroenterology; 2008 Apr; 134(4):905. PubMed ID: 18395067
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA user fee and Modernisation Act.
    Donawa M
    Med Device Technol; 2002 Dec; 13(10):27-9. PubMed ID: 12575526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA begins to act against black box excimer lasers.
    Kohl M
    J Refract Surg; 1997; 13(4):336-8. PubMed ID: 9268930
    [No Abstract]   [Full Text] [Related]  

  • 20. An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
    Peña C; Bowsher K; Costello A; De Luca R; Doll S; Li K; Schroeder M; Stevens T
    IEEE Trans Neural Syst Rehabil Eng; 2007 Sep; 15(3):421-4. PubMed ID: 17894274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.